Y-MABS THERAPEUTICS, ApS: Financial statements 2014
CVR: 34879524
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
Y-MABS THERAPEUTICS, ApS (CVR 34879524) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -14,665 and a net result of DKK -14,738 compared with DKK -87,930 the year before. Equity in the 2014 report amounted to DKK 72,332. The solvency ratio was 88.8%.
- Gross Profit
- DKK -14,665
- Profit/Loss
- DKK -14,738
- Equity
- DKK 72,332
- Total Assets
- DKK 81,460
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -15 t. | -15 t. | 72 t. | - |
| 2013 | - | -13 t. | -88 t. | -8 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
Y-MABS THERAPEUTICS, ApS has published its annual report for 2013. Gross profit came to DKK -12,930, and the net result was DKK -87,930.
About Y-MABS THERAPEUTICS, ApS
Y-MABS THERAPEUTICS, ApS was a Danish company of the type Anpartsselskab based in København K, founded in 2012. The company has been dissolved on 18 June 2020. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named EQ MEDICINE ApS. In 2014, the company reported a gross profit of DKK -14,665 and a net result of DKK -14,738 compared with DKK -87,930 the year before. Equity in the 2014 report amounted to DKK 72,332.